EFFECT OF CANNABIDIOL (CBD) ON CYTOCHROME P450 3A IN THE MOUSE

被引：0
|
作者：
BORNHEIM, LM
EVERHART, ET
LI, J
机构：
[1] UNIV CALIF SAN FRANCISCO,DEPT PHARMACOL,SAN FRANCISCO,CA 94143
[2] UNIV CALIF SAN FRANCISCO,CTR LIVER,SAN FRANCISCO,CA 94143
来源：
FASEB JOURNAL | 1993年 / 7卷 / 03期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A265 / A265
页数：1
相关论文
共 50 条
  • [41] Suppression of cytochrome P450 3A protein levels by proteasome inhibitors
    Zangar, RC
    Kocarek, TA
    Shen, S
    Bollinger, N
    Dahn, MS
    Lee, DW
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 305 (03): : 872 - 879
  • [42] Screening for cytochrome P450 3A in man: Studies with midazolam and nifedipine
    Yeates, RA
    Scharpf, F
    Laufen, H
    Zimmermann, T
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 1996, 48 (09) : 933 - 934
  • [43] A novel cytochrome P450 3A isoenzyme in rat intestinal microsomes
    Gushchin, GV
    Gushchin, MI
    Gerber, N
    Boyd, RT
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 255 (02) : 394 - 398
  • [44] Comparison of Cytochrome P450 3A Enzymes in Cynomolgus Monkeys and Humans
    Iwasaki, Kazuhide
    Murayama, Norie
    Koizumi, Ryo
    Uno, Yasuhiro
    Yamazaki, Hiroshi
    DRUG METABOLISM AND PHARMACOKINETICS, 2010, 25 (04) : 388 - 391
  • [45] Effects of Intestinal Flora on the Expression of Cytochrome P450 3A in the Liver
    Ishii, Makoto
    Toda, Takahiro
    Ikarashi, Nobutomo
    Ochiai, Wataru
    Sugiyama, Kiyoshi
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2012, 132 (03): : 301 - 310
  • [46] Porcine cytochrome P450 3A: current status on expression and regulation
    Rasmussen, Martin Kroyer
    ARCHIVES OF TOXICOLOGY, 2020, 94 (06) : 1899 - 1914
  • [47] The effects of portal shunts on intestinal cytochrome P450 3A activity
    Rostami-Hodjegan, A
    Tucker, GT
    HEPATOLOGY, 2002, 35 (06) : 1549 - 1550
  • [48] Bimodal distribution of renal cytochrome P450 3A activity in humans
    Haehner, BD
    Gorski, JC
    Vandenbranden, M
    Wrighton, SA
    Janardan, SK
    Watkins, PB
    Hall, SD
    MOLECULAR PHARMACOLOGY, 1996, 50 (01) : 52 - 59
  • [49] Prediction of cytochrome P450 3A inhibition by verapamil enantiomers and their metabolites
    Wang, YH
    Jones, DR
    Hall, SD
    DRUG METABOLISM AND DISPOSITION, 2004, 32 (02) : 259 - 266
  • [50] The influence of age and sex on the clearance of cytochrome P450 3A substrates
    Cotreau, MM
    von Moltke, LL
    Greenblatt, DJ
    CLINICAL PHARMACOKINETICS, 2005, 44 (01) : 33 - 60
12345